Liposomal Bupivacaine Block at the Time of Cesarean Delivery to Decrease Postoperative Pain: A Randomized Controlled Trial
- PMID: 30461673
- DOI: 10.1097/AOG.0000000000002976
Liposomal Bupivacaine Block at the Time of Cesarean Delivery to Decrease Postoperative Pain: A Randomized Controlled Trial
Comment in
-
In Reply.Obstet Gynecol. 2018 Dec;132(6):1503-1504. doi: 10.1097/AOG.0000000000002977. Obstet Gynecol. 2018. PMID: 30461674 No abstract available.
Comment on
-
Liposomal Bupivacaine Block at the Time of Cesarean Delivery to Decrease Postoperative Pain: A Randomized Controlled Trial.Obstet Gynecol. 2018 Jul;132(1):70-78. doi: 10.1097/AOG.0000000000002649. Obstet Gynecol. 2018. PMID: 29889750 Clinical Trial.
References
-
- Prabhu M, Clapp MA, McQuaid-Hanson E, Ona S, O'Donnell T, James K, et al. Liposomal bupivacaine block at the time of cesarean delivery to decrease postoperative pain: a randomized controlled trial. Obstet Gynecol 2018;132:70–8.
-
- Gorfine SR, Onel E, Patou G, Krivokapic ZV. Bupivacaine extended-release liposome injection for prolonged postsurgical analgesia in patients undergoing hemorrhoidectomy: a multicenter, randomized, double-blind, placebo-controlled trial. Dis Colon Rectum 2011;54:1552–9.
-
- Cooper SA, Desjardins PJ, Turk DC, Dworkin RH, Katz NP, Kehlet H, et al. Research design considerations for single-dose analgesic clinical trials in acute pain: IMMPACT recommendations. Pain 2016;157:288–301.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources